Indeed, targeting fibrosis using a TGF-β neutralizing antibody in the STAMTM model of murine HCC, we found that ameliorating the fibrotic environment could facilitate redistribution of CD8+ lymphocytes into tumors. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.